Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Mupirocin

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    17 result(s) found for: Mupirocin. Displaying page 1 of 1.
    EudraCT Number: 2014-005308-12 Sponsor Protocol Number: 1111 Start Date*: 2018-09-07
    Sponsor Name:Region Sjælland, Slagelse Hospital
    Full Title: Treatment of MRSA throat carriage with mupirocin irrigation
    Medical condition: Patientents being MRSA positive for a minimum of 6 months and concluded at least one konventional topical treatments unsuccessfully
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10061554 Staphylococcal pharyngitis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2018-001505-90 Sponsor Protocol Number: 18CH049 Start Date*: 2018-10-01
    Sponsor Name:CHU de Saint Etienne
    Full Title: Decolonization of patients carrying S. aureus before cardiac surgery: study of the risk factors associated with failure
    Medical condition: Decolonization of S. aureus nasal carriers before cardiac surgery
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10075981 Staphylococcus aureus infection LLT
    20.0 100000004865 10048935 Open heart surgery LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-002223-25 Sponsor Protocol Number: AGO/2015/007 Start Date*: 2015-08-18
    Sponsor Name:Ghent University Hospital
    Full Title: Eradication of methicillin-susceptible Staphylococcus aureus nasal carriage in patients undergoing dialysis: can fusidic acid be used as an alternative to mupirocin?
    Medical condition: persistent nasal Staphylococcus aureus carriage
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2018-002913-37 Sponsor Protocol Number: MPN-001-07-2018 Start Date*: 2019-03-13
    Sponsor Name:Antibiotic-Razgrad AD
    Full Title: Multicenter, prospective, randomized, double-blind, two-armed phase IV clinical study for efficacy and safety assessment of two 2% mupirocin containing nasal ointments (MupiroNasal 20mg/g, nasal oi...
    Medical condition: For elimination/eradication of nasal carriage of staphylococci, including methicillin-resistant Staphylococcus aureus (MRSA)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BG (Completed)
    Trial results: View results
    EudraCT Number: 2010-019727-55 Sponsor Protocol Number: MRSA-2010 Start Date*: 2010-08-17
    Sponsor Name:
    Full Title: Eradikeringsbehandling av MRSA- en jämförelse av kombinerad systemisk antibiotikabehandling och lokal mupirocinbehandling med enbart mupirocin för att eradikera MRSA vid svalgbärarskap
    Medical condition: MRSA-bärarskap
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-002001-30 Sponsor Protocol Number: IMUP Start Date*: 2011-12-09
    Sponsor Name:INFECTOPHARM Arzneimittel und Consilium GmbH
    Full Title: Multicenter, prospective, double-blind, two-armed phase III study for efficacy and safety of the topic impetigo therapy of two 2 % mupirocin ointments
    Medical condition: Impetigo
    Disease:
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-022701-17 Sponsor Protocol Number: 1709801154 Start Date*: 2015-11-17
    Sponsor Name:Isala
    Full Title: Reduction of surgical-site infection in hip and knee arthroplasty: the influence of perioperative mupirocin nasal ointment and chlorhexidine soap in a double-blind, randomized, multicentre, placebo...
    Medical condition: osteoarthritis of hip and knee, prevention of surgical site infections after arthroplasty
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-017398-39 Sponsor Protocol Number: HT-04 Start Date*: 2010-02-02
    Sponsor Name:Helperby Thearapeutics Ltd
    Full Title: Randomised double-blind, vehicle controlled dosing frequency study of HT61 1% gel applied to the anterior nares plus chlorhexidine body and hair washes in subjects with nasal carriage of Staphyloco...
    Medical condition: Nasal carriage of Staphylococcus aures (including MRSA)
    Disease: Version SOC Term Classification Code Term Level
    12 10067910 Staphylococcal colonisation LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-006928-18 Sponsor Protocol Number: 06/Q0603/57 Start Date*: 2007-04-25
    Sponsor Name:Barts and The London NHS Trust
    Full Title: Randomised trial of Prontosan wound gel for prevention of exit site infection in peritoneal dialysis patients
    Medical condition: Peritoneal dialysis patients and their peritoneal dialysis catheter exit site care.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10008831 Chronic ambulatory peritoneal dialysis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-020206-14 Sponsor Protocol Number: 09.0058 Start Date*: 2011-01-31
    Sponsor Name:St George's University of London
    Full Title: Evaluation study of Meticillin Resistant Staphylococcus aureus (MRSA) during routine nasal decolonisation programmes with Bactroban Nasal® ointment, Chlorhexidine Gluconate 4% body and hair wash, a...
    Medical condition: MRSA
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-002450-69 Sponsor Protocol Number: RJ-NBC01 Start Date*: 2013-11-26
    Sponsor Name:Laboratorio Reig Jofré S.A
    Full Title: Estudio de fase III, aleatorizado, abierto con evaluación ciega, multicéntrico, de no-inferioridad, con control activo y con placebo, para evaluar la seguridad y la eficacia de la aplicación tópica...
    Medical condition: Impetigo
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10021531 Impetigo PT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-001204-23 Sponsor Protocol Number: MUFU001-SA-01 Start Date*: 2008-09-01
    Sponsor Name:Dra. Beatriz Sanchez Sobrino
    Full Title: Estudio comparativo de mupirocina versus acido fusidico tópico en la erradicación de portadores nasales de Staphylococcus aureus en pacientes con insuficiencia renal crónica en hemodiálisis por cat...
    Medical condition: Pacientes con insuficiencia renal crónica estadio 5 en Hemodialisis que se encuentren realizando la técnica mediante un acceso vascular tipo catéter central permanente tunelizado portadores nasales...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-003501-33 Sponsor Protocol Number: DECOLAD Start Date*: 2016-12-01
    Sponsor Name:AntibioTx ApS
    Full Title: A prospective, single center, randomized, double-blind, placebo controlled study in two phases to evaluate the safety and efficacy of ATx201 as a topical antibiotic agent
    Medical condition: AntibioTx has developed a topical product (ATx201) for treatment of infected eczema and infected atopic dermatitis. These infections are predominantly caused by Staphyllococcus aureus and various s...
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10040788 Skin and subcutaneous tissue bacterial infections HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2011-002438-38 Sponsor Protocol Number: HT-09 Start Date*: 2012-02-21
    Sponsor Name:Helperby Therapeutics Limited
    Full Title: An open-label, multiple dose, efficacy study of HT61 in combination with marketed antibiotics, applied to the anterior nares in subjects with nasal carriage of Staphylococcus aureus (S. aureus).
    Medical condition: Nasal carriage of Staphylococcus aureus (including MRSA)
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10067914 Staphylococcal colonisation LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2014-000228-52 Sponsor Protocol Number: P-110881-01 Start Date*: 2014-06-03
    Sponsor Name:Ferrer Internacional, SA
    Full Title: A phase III 2 arms, multicenter, randomised, double-blind study to assess the efficacy and safety of ozenoxacin 1% cream applied twice daily for 5 days versus placebo in the treatment of patients w...
    Medical condition: Impetigo
    Disease:
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) RO (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-021193-11 Sponsor Protocol Number: HT-07 Start Date*: 2010-09-14
    Sponsor Name:Helperby Thearapeutics Ltd
    Full Title: A randomised, open-labelled, multiple dose study of HT61 formulations applied to the anterior nares plus chlorhexidine body and hair washes in subjects with nasal carriage of Staphylococcus aureus
    Medical condition: Nasal carriage of Staphylococcus aureus (including MRSA)
    Disease: Version SOC Term Classification Code Term Level
    13 10067914 Staphylococcal colonisation LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-003032-31 Sponsor Protocol Number: P-110880-01 Start Date*: 2012-02-22
    Sponsor Name:Ferrer Internacional, S.A.
    Full Title: A phase III 3 arms, multicenter, randomised, investigator-blind study to assess the efficacy and safety of ozenoxacin 1% cream applied twice daily for 5 days versus placebo in the treatment of pati...
    Medical condition: Impetigo
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10021531 Impetigo PT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 07 08:32:15 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA